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ABSTRACT The intersegmental muscles of the tobacco
hawkmoth Manduca sexta die during the 36-hr period after
metamorphosis. The trigger for cell death is a fall in the
ecdysteroid titer. Commitment of the intersegmental muscles to
degenerate involves selective repression and activation of
ecdysteroid-responsive genes. When the pattern ofgene expres-
sion is altered after injection of either 20-hydroxyecdysone or
actinomycin D, the muscles persist. cDNA clones have been
isolated for four genes that become abundantly expressed
coincident with the commitment to degenerate. The data
presented here indicate that programmed cell death is not due
to the cessation ofmacromolecular synthesis in condemned cells
but rather is due to the activation of a differentiative pathway.
During both embryonic and post-embryonic development,
many cells die by a process that appears to be independent of
age-related senescence (1). This developmentally pro-
grammed cell death serves a variety of functions in different
systems. For example, much of the sculpting of the body
form involves the removal of unneeded cells, such as in the
formation of the digits during embryogenesis (2). Cell death
can also serve to adjust the number of neurons innervating
either central or peripheral targets (3). As well, cell death can
remove obsolete tissues during development, as occurs dur-
ing metamorphosis in amphibia (4) and insects (5, 6).
Despite the ubiquity of programmed cell death, there is
relatively little information available regarding either the
triggers or mechanisms that mediate this process. In the
embryonic chicken nervous system, motor neuron degener-
ation appears to be regulated by competition among neurons
for peripheral muscle targets (3). A muscle-derived "troph-
ic" factor is currently being purified for characterization (7).
In the nematode Caenorhabditis elegans, the trigger(s) re-
sponsible for programmed cell death are unknown, although
several mutations have been identified that block normal
patterns of neuron loss (8, 9). The molecular isolation and
characterization of the genes containing these mutations may
provide considerable insight into the mechanisms of cell
death.
Another system that has proven useful for the analysis of
cell death is the intersegmental muscles (ISMs) of Lepi-
doptera (10). Each fiber within these muscles is approxi-
mately 5 mm long and 1 mm in diameter. The fibers are
organized in sheets that span each of the abdominal segments
in the larva. After pupation, the ISMs in the first two and last
two segments degenerate, leaving four segments of intact
muscle remaining. The ISMs are then retained until 3 days
before adult eclosion (day 15 of development) at which point
they begin to atrophy. Atrophy results in a loss of 40% of
muscle mass, without any change in resting potential, force/
cross sectional area, or skinned-fiber calcium sensitivity
(L.M.S., unpublished data). The ISMs are used during the
performance of the eclosion (emergence) behavior on day 18,
the last day of pupal/adult development. After eclosion, the
ISMs are no longer needed by the animal and undergo a rapid
degeneration during the subsequent 36-hr period (11).
In the tobacco hawkmoth Manduca sexta, the trigger for
ISM atrophy and degeneration is a decline in the insect
molting hormone, 20-hydroxyecdysone (20-HE) (12). When
the ecdysteroid titer falls below a specific threshold on day 15
of development, the muscles begin to atrophy. If the ecdy-
steroid titer is artificially maintained at this intermediate level
by injection of 20-HE, the muscles do not degenerate but
instead continue to atrophy. During normal development,
there is a natural decline in the ecdysteroid titer early on day
18, which commits the ISMs to degenerate. Once committed,
the muscles cannot be rescued with exogenous hormone.
One plausible mechanism for initiating ISM degeneration
could be the cessation of transcription and/or translation.
Blockage of either process might then allow degradation of
cellular constituents to outstrip synthesis, resulting in the loss
of cellular mass. We have examined transcriptional and
translational activity of ISMs during development in the
hawkmoth M. sexta. We report here that the commitment of
the muscle to die does not involve metabolic shutdown but
rather does involve selective regulation of gene expression in
the muscles.
EXPERIMENTAL PROCEDURES
Animals. The tobacco hawkmoth, M. sexta, was reared as
described (12). Comparably sized animals were staged during
development according to specific cuticular markers. In
some experiments, animals were injected with pharmacolog-
ical agents [actinomycin D (ActD) and 20-HE; Sigma] or
radioisotopes. A Hamilton syringe was used to introduce
10-25 1ul into the dorsal thorax.
Insects were dissected under saline (12) and the lateral
ISMs were removed for assay. Where muscle mass was
determined, the ISMs were placed on preweighed foil, dried
at 60°C overnight, and then reweighed. The mass of the
muscle is expressed as {[mg of ISMs (dry weight)/gram of
body weight] x 1000}.
Protein Gels. Individual staged insects were injected with
500 ,Ci (1 Ci = 37 GBq) of Trans 35S-Label ([35S]methionine;
ICN) and maintained at room temperature for 5.5 hr. The
lateral ISMs were rapidly dissected free and all adhering fat
body and trachea were removed. The samples were homog-
enized in loading buffer, boiled, and fractionated in one
dimension with 10% polyacrylamide gels containing SDS
(13). Equal amounts of protein were loaded per lane. Gels
were incubated in EN3HANCE (NEN), dried, and fluoro-
graphed with Kodak XAR x-ray film.
Abbreviations: ISM, intersegmental muscle; 20-HE, 20-hydroxy-
ecdysone; ActD, actinomycin D.
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[35S]Methionine-labeled ISM proteins were also fraction-
ated by two-dimensional polyacrylamide gel electrophoresis
as described by O'Farrell (14) and Garrels (15). In vivo-
labeled samples were solubilized in 2% (wt/vol) SDS/50 mM
Tris-HCl, pH 6.7/5% (vol/vol) 2-mercaptoethanol/0.005%
butylated hydroxytoluene and boiled for 2 min. The SDS was
removed by adding Nonidet P-40 nonionic detergent in an
8-fold excess to the SDS (wt/wt) (16). Samples were then
focused on narrow-range ampholines (pH 5-7) and size-
fractionated on a 10% polyacrylamide gel.
RNA. The ISMs have high levels of RNase (L.M.S., un-
published data), and so great care was required in isolating
RNA. Animals were rapidly dissected under ice-cold saline
and the ISMs were frozen in liquid nitrogen. Groups of
muscles from approximately 20 animals were homogenized
with a Tissuemizer (Tekmar, Cincinnati, OH) in 4 M guani-
dinium isothiocyanate extraction buffer as described by Mac-
Donald et al. (17). Total RNA was isolated by centrifugation
through a 5.7 M CsCl pad. The pellet was resuspended in 5%
2-mercaptoethanol/0.5% sarkosyl/5 mM EDTA, phenol/
chloroform-extracted, and ethanol-precipitated. Poly(A)+
RNA was isolated by oligo(dT)-cellulose chromatography
(18).
For Northern blots, 15 Ag of total RNA was denatured in
formaldehyde and separated by size in 1.5% agarose (19)
prior to transfer to Zeta-Probe membranes (Bio-Rad). Blots
were hybridized overnight at 650C under stringent conditions
in 1 mM EDTA/7% SDS/0.5 M NaH2PO4, pH 7.2. The
32P-labeled DNA probes are described below. Blots were
autoradiographed with Kodak XAR film.
RNA was translated in vitro with a rabbit reticulocyte
lysate from Stratagene using [35S]methionine (Amersham).
Protein products were analyzed as above.
Library Construction. cDNA was synthesized from day 18
ISM poly(A)+ RNA with a cDNA synthesis kit (Boehringer
Mannheim), ligated to EcoRI linkers, and cloned into AgtlO.
The library had approximately 86,000 original recombinants,
with an average insert size of600 base pairs and was amplified
once before use. High specific activity single-stranded 32p_
labeled cDNA was synthesized with avian myeloblastosis
virus reverse transcriptase (International Biotechnologies)
and oligo(dT) as described by Gerard (20). Individual plaques
were picked and transferred to duplicate Escherichia coli
lawns and lifts were taken with nylon filters (Micron Sepa-
ration, Westboro, MA). Clones were screened by differential
hybridizations with radioactive cDNAs from day 15 (pre-
commitment) and day 18 (post-commitment) mRNA (plus/
minus screening). Recombinants that displayed differential
labeling with the two probes were rescreened to verify the
initial observation. Inserts were then isolated by polymerase
chain reaction amplification using primers that flanked the
EcoRI sites in AgtlO (21). Inserts were nick-translated (22)
and used to probe Northern blots (above).
RESULTS
Patterns of Protein Expression. To determine the synthetic
capacity of the ISMs, individual insects were injected with
[35S]methionine at various stages of pupal-adult develop-
ment. After a 5.5-hr equilibration period, the ISMs were
isolated and the cellular proteins were fractionated by SDS/
polyacrylamide gel electrophoresis. As can be seen in Fig. 1,
the ISMs displayed active protein synthesis at all stages
examined, with little apparent quantitative difference.
Careful examination of this figure reveals several protein
bands that are apparent only at select stages of development.
To obtain better resolution of the patterns of protein expres-
sion associated with the commitment of the muscles to
degenerate, radio-labeled proteins were fractionated by two-
dimensional polyacrylamide gel electrophoresis. The times





FIG. 1. Patterns of ISM protein synthesis during development.
Individual insects were injected with [35S]methionine. After a 5.5-hr
equilibration period, the ISMs were removed and homogenized, and
protein extracts were fractionated on a 10% polyacrylamide gel.
Newly synthesized radioactive proteins were detected by fluorog-
raphy. d, Day of development. Molecular masses in kDa are indi-
cated to the left.
selected for examination were days 17 and 18 of develop-
ment, since the ISMs become committed to degenerate early
on day 18 (12). The majority of the ISM proteins were
expressed at both stages of development (Fig. 2). However,
subsets of proteins were developmentally regulated, in that
they were substantially more abundant at one stage of




FIG. 2. Patterns of newly synthesized ISM proteins before and
after the commitment to degenerate. ISM proteins were labeled as in
Fig. 1 and then fractionated by two-dimensional polyacrylamide gel
electrophoresis. Ampholines used in the first dimension were from
pH 4 to pH 6 (left-to-right on the gel). The second dimension was
fractionated on a 10%1 polyacrylamide gel. (A) Day 17 of develop-
ment. (B) Day 18 of development. Solid arrowheads denote proteins
that were abundantly expressed on day 17 (prior to commitment to
degenerate) but reduced or absent on day 18 (subsequent to com-
mitment). Open triangles identify proteins that were abundant on day
18 but not on day 17. Proteins 1-3 are representative of the former
class; proteins 4-7 are representative of the latter.
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were present in the day 17 sample but had a reduced intensity
in the day 18 sample. Representative of this group were
proteins designated 1, 2, and 3, which were acidic low
molecular mass proteins (-25 kDa; pI -5.2). Interestingly,
these proteins could still be seen on silver-stained gels from
day 18 (data not shown), suggesting that their absence was
due to reduced synthesis rather than enhanced degradation.
Whereas the synthesis of some proteins was decreased
between days 17 and 18, the expression of another group of
proteins was increased. Representative of this group were
proteins 4-7. Although all four of these proteins were unde-
tectable on day 17, they were abundantly expressed on day
18.
It is possible that these developmental changes in protein
expression were unrelated to the commitment of the ISMs to
degenerate. To address this concern, animals were treated
with pharmacological agents that block ISM degeneration.
The two compounds used were 20-HE and the transcriptional
inhibitor ActD. Individual insects were injected late on day
17 of development with either 20-HE at 5 ,g/g (12) or ActD
at 0.1 ,tg/g. When examined on day 19, the ISMs of control
animals were degenerate and noncontractile, but those of
treated animals were comparable to that of preeclosion
animals (Fig. 3). Grossly, the ISMs from treated animals
appeared to be identical to muscles from control preeclosion
animals. Once the ecdysteroid titer declined in 20-HE-treated
animals, the ISMs did subsequently degenerate (12). How-
ever, the ISM degeneration was not observed in ActD-treated
animals, even when examined 6 days after drug injection
(L.M.S., unpublished data).
Since 20-HE and ActD blocked ISM degeneration at the
normal time in development, we examined their effects on de
novo protein synthesis. Individual animals were injected on
day 17 with 20-HE or ActD and then reinjected on day 18 with
[35S]methionine, and the ISM proteins were fractionated on
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FIG. 3. Effects of ActD and 20-HE on ISM degeneration. The
mass of the ISMs was determined after treatment and then normal-
ized to the weight of the insect {[mg of ISMs (dry weight)/g of body
weight] x 1000}. Histogram bars for d17-d19 show the normal
decline in ISM weight after the completion of the atrophy program
and the initiation of degeneration. Test animals were injected on day
17 and their muscle mass was measured on day 19, 16 hr after the time
of eclosion. Test insects received either ActD at 0.1 t'g/g or 20-HE
at 5 tLg/g. Numbers in parentheses are the number of insects tested.
Values are mean ± SEM.
not toxic to the muscles, since the ISMs were biosyntheti-
cally active 24 hr after treatment. The patterns of expression
seen on these gels were similar to that seen in day 18 control
ISMs (Fig. 4). For example, the normal reduction in proteins
1, 2, and 3 was still observed in these muscles. However,
pretreatment did block the appearance of some of the newly
synthesized day 18 proteins. For instance, proteins 4 and 7
were expressed in the steroid-treated muscles, but proteins 5
and 6 were not. In the ActD-injected animal, proteins 4, 5,
and 6 were present in the ISMs, but protein 7 was absent.
Therefore, subtle perturbations in the patterns of proteins
made by the ISMs had a profound effect on their develop-
ment.
Changes in RNA Expression. The data presented above
suggest that ISM degeneration is associated with both the loss
and appearance of several proteins. We next sought to
determine whether these changes were regulated at the level
of transcription or translation. RNA was isolated from mus-
cles at eight developmental stages, ranging from prior to
atrophy to well into the degeneration phase. In addition, one
group of animals was treated with 20-HE on day 17 and RNA
was isolated from their ISMs 5 hr after the time of normal
eclosion on day 18. Each sample was translated in vitro in the
presence of [35S]methionine, and the protein products were
fractionated by one-dimensional polyacrylamide gel electro-
phoresis (Fig. 5). At each stage examined, there was a full
size range of proteins synthesized, suggesting that the RNA
was intact and translatable. The majority of the synthesized
proteins were comparably expressed at each developmental
stage, which supports their role as "housekeeping" se-
quences. However, there were a small number of develop-
mentally regulated transcripts as well. Most dramatic were
the protein products that disappeared coincident with com-
mitment. Seven such RNAs were abundantly expressed
between days 14 and 17 but were reduced or missing at the
time of commitment. Conversely, products from an addi-
tional seven of the RNAs were apparent on day 18 but were











FIG. 4. Effects ofActD and 20-HE on in vivo protein expression.
Animals were treated with either drug on day 17, as described in Fig.
3, and injected on day 18 with [35S]methionine, and the proteins were
fractionated as in Fig. 2. (A) 20-HE. (B) ActD. Solid arrowheads
identify the location of the proteins that were down-regulated be-
tween days 17 and 18 in control animals. Open triangles identify the
location of the proteins that normally appear coincident with muscle
commitment to degenerate (see Fig. 2).
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FIG. 5. In vitro translation of ISM RNA during development.
Equal amounts of RNA for each stage of development were trans-
lated in vitro with a rabbit reticulocyte lysate in the presence of
[35S]methionine. The newly synthesized proteins were fractionated
in 10% polyacrylamide gel (A) or in 12% polyacrylamide gel (B). (The
molecular mass for the up-regulated protein in B is not known, since
this was in a nonlinear region of the gel.) Solid arrowheads identify
proteins from RNAs that were expressed primarily before commit-
ment (day 18); open triangles show proteins from RNAs that ap-
peared after commitment. D, day of development; 20-HE, animals
pretreated on day 17 with 20-HE and examined 5 hr after the normal
time of eclosion; hr, time (hr) after adult eclosion (emergence).
Molecular masses in kDa are indicated to the left in A.
with 20-HE greatly reduced the developmental changes in the
coding potential of the ISM RNA, producing a pattern that
was intermediate between patterns at days 17 and 18.
Isolation of cDNA Clones. From the findings above, we
suspected that a number ofthe newly expressed ISM proteins
were encoded by differentially expressed mRNAs. To char-
acterize these sequences and their presumptive protein prod-
ucts, we used mRNA from day 18 of development to con-
struct a cDNA library in AgtlO. The library was screened with
single-stranded 32P-labeled cDNA made from poly(A)+ RNA
isolated from the muscles on days 15 (precommitment) and 18
(post-commitment). After several rounds of screening, 40
clones were isolated that were labeled more strongly with the
cDNA from day 18 than day 15. After screening for duplicate
recombinants, four unique clones were isolated, 18-2, 18-5,
18-8, and 18-13. In addition, two clones that gave equal
signals with each probe were selected as controls (clones
18-10 and 15-3).
RNA was isolated from the ISMs at several developmental
stages and from animals pretreated with 20-HE. The RNA
was fractionated in agarose and blotted to membranes. These
Northern blots were then hybridized with radio-labeled
probes from each of the recombinants described above (Fig.
6). Clones 15-3 and 18-10 labeled constitutively expressed
transcripts that were unaffected by developmental stage or
steroid treatment. In contrast, all four of the recombinants
isolated by plus/minus screening labeled transcripts whose
abundance changed during development. The mRNA corre-
18-10
FIG. 6. Northern blots labeled with select cDNA clones. ISM
RNA was isolated from animals at various stages ofdevelopment and
from animals pretreated with 20-HE. Total RNA (15 dig) from each
stage was fractionated in 1.5% agarose under denaturing conditions
and transferred to Zeta-Probe membranes. Ethidium bromide was
included in the RNA samples, so that rRNA could be visualized after
fractionation to ensure equal loading of RNA. Blots were probed
with 32P-labeled cDNA from individual clones isolated by plus/
minus screening of a day 18 cDNA library. Blots were exposed for
comparable lengths of time and, in most cases, were stripped of
probe and reprobed with another labeled clone. Day 18 ISM RNA
was included from animals pretreated on day 17 with 20-HE.
sponding to clone 18-5 was undetectable until day 18, at
which point it became an abundant transcript. RNAs labeled
by clones 18-8 and 18-13 were present prior to commitment,
although at markedly reduced levels. Clone 18-2 labeled
members of the multigene family within the ISMs. One
transcript was constitutively expressed, whereas others were
developmentally regulated. The transiently expressed tran-
scripts were present at low level during the early phases of
atrophy (days 15 and 16), disappeared on day 17, and then
were abundant coincident with commitment. In all cases,
expression of the developmentally regulated transcripts was
repressed by pretreatment with 20-HE, but constitutively
expressed transcripts were unaffected. These data support
the contention that cell death is associated with increased
expression of certain genes.
DISCUSSION
Programmed cell death has been observed during the devel-
opment of virtually all metazoan organisms (1). In the few
cases that have been characterized, cells appear to die either
in response to a specific trigger (4, 11) or by the disappear-
ance of a required trophic factor (7, 12, 23). Historically, the
general assumption has been that once a cell is fated to die,
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waste away (24). More recently, several investigators have
shown that programmed cell death can be blocked with
transcriptional inhibitors, suggesting a role for regulation of
gene expression (4, 25-27). In this study, we have shown that
ISM degeneration requires activation of genes in a differen-
tiative pathway and we have cloned several of these pre-
sumptive cell-death genes.
When the ISMs of Manduca become committed to degen-
erate, they express a complement of cell-death genes. We
have isolated cDNA clones for four such cell-death genes.
The identity of one of these clones (18-2) has been deter-
mined. Clone 18-2 encodes for the protein ubiquitin and in
RNA blotting experiments cross-hybridizes with both con-
stitutively and developmentally regulated transcripts. The
constitutively expressed transcript encodes a ubiquitin fusion
protein, which does not appear to play a role in programmed
cell death (S. T. Bishoff and L.M.S., unpublished data). The
developmentally regulated transcript encodes polyubiquitin
(32; A. Myer and L.M.S., unpublished data). Several lines of
evidence suggest that ubiquitin plays a role in ISM degener-
ation (32; A. L. Haas and L.M.S., unpublished data). The
observation that ubiquitin functions to target proteins for
degradation by a nonlysosomal proteinase (28) may explain
why polyubiquitin transcripts are seen during ISM atrophy
and degeneration. Interestingly, ubiquitin has been shown to
be a component of the cytoplasmic inclusions of Alzheimer
and several other neurodegenerative diseases (29, 30). Our
results suggest that ubiquitin may play an important role in
both normal and pathological cell death.
Besides increasing the expression of several genes, com-
mitment is also associated with the apparent repression of
certain genes. We have identified two of these down-
regulated transcripts as the products of the actin and myosin
genes (L.M.S. and L.K., unpublished data). The identities of
the other regulated genes are unknown. Some may encode
other contractile proteins. It is interesting to speculate that
other regulated genes may encode products that play a
negative role in the commitment process, such as repressing
cell-death gene expression. Alternatively, they may encode
ecdysteroid-responsive sequences that were used by the
ISMs at earlier stages ofdevelopment but are unrelated to the
cell-death process. We have made a cDNA library from
precommitment ISM poly(A)+ RNA, so that recombinants
encoding these repressed genes can be isolated for charac-
terization.
It appears that 20-HE modulates these developmental
changes in ISM gene expression. Between days 17 and 18 of
development, there is a decline in the circulating ecdysteroid
titer that commits the ISMs to degenerate (12). During this
time interval, a number of specific mRNAs and proteins
either increase or decrease in abundance in the ISMs. When
20-HE is injected into day 17 animals, cell death can be
delayed and macromolecular synthesis in the ISMs is per-
turbed. The ISMs do subsequently degenerate, presumably
due to a decline in the titer of the injected hormone.
We interpret the inhibitory effect of ActD on the ISM
cell-death program to be at the level of transcription. Ad-
ministration of ActD to day 17 animals prevents the loss of
the ISMs for up to 6 days after eclosion. This pharmacolog-
ical block of ISM degeneration is accompanied by the ab-
sence of specific proteins that normally appear in the con-
demned ISMs. Interestingly, a few proteins do appear de
novo in the ISMs after ActD treatment, which suggests that
there may be translational as well as transcriptional control
in this system. However, expression of these proteins ap-
pears to be insufficient to direct cell death, as other regula-
tory gene products may be necessary.
In the various metazoa examined to date, programmed cell
death is initiated in a reproducible temporal and spatial
pattern. It is clear that different cells use distinct triggers to
initiate this program. For example, the trigger for ISM
degeneration in Manduca is a decline in the ecdysteroid titer,
whereas in a related moth, Antheraea polyphemus, the
trigger is the peptide eclosion hormone (5). However, once
the 1SMs are committed to degenerate, the appearance of the
cells seems to be the same in both species (31). It seems
reasonable to speculate that the genes involved in mediating
cell death in these moths, as well as other organisms, are
conserved. The isolation and characterization of cell-death
genes in simpler systems, such as moths and nematodes, will
facilitate the examination of these basic developmental pro-
cesses in other organisms.
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